Abstract
Hepatocellular carcinoma is the third most common cause of cancer-related death. In the past few years, staging systems have been developed that enable patients to be stratified into treatment algorithms in a multidisciplinary setting. Several of these treatments involve minimally invasive image-guided therapy that can be performed by radiologists.
MeSH terms
-
Algorithms
-
Carcinoma, Hepatocellular / drug therapy
-
Carcinoma, Hepatocellular / pathology
-
Carcinoma, Hepatocellular / radiotherapy
-
Carcinoma, Hepatocellular / surgery
-
Carcinoma, Hepatocellular / therapy*
-
Catheter Ablation*
-
Chemoembolization, Therapeutic / methods*
-
Contraindications
-
Drug Implants
-
Ethanol / administration & dosage
-
Ethanol / therapeutic use
-
Ethiodized Oil / administration & dosage
-
Ethiodized Oil / therapeutic use
-
Hepatectomy / methods
-
Hepatic Artery
-
Humans
-
Injections, Intra-Arterial
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / pathology
-
Liver Neoplasms / radiotherapy
-
Liver Neoplasms / surgery
-
Liver Neoplasms / therapy*
-
Liver Transplantation
-
Magnetic Resonance Imaging, Interventional
-
Microspheres
-
Minimally Invasive Surgical Procedures
-
Neoplasm Staging
-
Radiography, Interventional
-
Randomized Controlled Trials as Topic
-
Retrospective Studies
-
Sclerotherapy
-
Yttrium Radioisotopes / administration & dosage
-
Yttrium Radioisotopes / therapeutic use
Substances
-
Drug Implants
-
Yttrium Radioisotopes
-
Ethanol
-
Ethiodized Oil